FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Russell Pieper

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Motokazu Ito; Joydeep Mukherjee; Shigeo Ohba; Karin Gaensler; Sabrina M Ronen; Russell O Pieper
Early chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage.
Joydeep Mukherjee; Joanna J Phillips; Sabrina M Ronen; John Wiencke; Shichun Zheng; Russell O Pieper
Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
Wendy L See; I-Li Tan; Joydeep Mukherjee; Theodore paul nicolaides; Russell O Pieper
Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Russell Pieper (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Motokazu Ito; Joydeep Mukherjee; Shigeo Ohba; Karin Gaensler; Sabrina M Ronen; Russell O Pieper
Early chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage.
PloS one 2013;8(5):e62351.
2013: Joydeep Mukherjee; Joanna J Phillips; Sabrina M Ronen; John Wiencke; Shichun Zheng; Russell O Pieper
Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
PloS one 2013;8(2):e57610.
2012: Wendy L See; I-Li Tan; Joydeep Mukherjee; Theodore paul nicolaides; Russell O Pieper
Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency.
Cancer research 2012;72(13):3350-9.
2011: Frederico Moreira; Russell O Pieper; Kelvin So; Tim-Rasmus Kiehl; Norbert F Ajeawung; Peter Gould; Carmelita Honculada; Deepak Kamnasaran
NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.
The American journal of pathology 2011;179(1):462-76.
2011: Dongyan Wang; Mitchell A Olman; Jerry Stewart; Russell Tipps; Ping Huang; Paul W Sanders; Eric Toline; Richard A Prayson; Jeongwu Lee; Cheryl A Palmer; G Yancey Gillespie; Wei Michael Liu; Russell O Pieper; Jun-Lin Guan; Robert J Weil; Candece L Gladson
Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.
PloS one 2011;6(5):e19629.
2011: Jean Lee Nakamura; Connie Phong; Emile Pinarbasi; Scott C Kogan; Scott Vandenberg; Andrew E Horvai; Bruce A Faddegon; Dorothea Fiedler; Kevan Shokat; Benjamin T Houseman; Richard Chao; Russell O Pieper; Kevin Shannon
Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.
Cancer research 2011;71(1):106-15.
2010: James S Waldron; Isaac Yang; Seunggu Han; Tarik Tihan; Michael E Sughrue; Steven A Mills; Russell O Pieper; Andrew T Parsa
Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2010;17(12):1543-7.
2010: Amith Panner; Courtney A Crane; Changjiang Weng; Alberto Feletti; Shanna Fang; Andrew T Parsa; Russell O Pieper
Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Cancer research 2010;70(12):5046-53.
2010: Bingbing Dai; Russell O Pieper; Dawei Li; Ping Wei; Mingguang Liu; Shiao Y Woo; Kenneth D Aldape; Raymond Sawaya; Keping Xie; Suyun Huang
FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
Cancer research 2010;70(7):2951-61.
2009: Seunggu J Han; Brian J Ahn; James S Waldron; Isaac Yang; Shanna Fang; Courtney A Crane; Russell O Pieper; Andrew T Parsa
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion.
Neuroreport 2009;20(18):1597-602.
2009: Amith Panner; Courtney A Crane; Changjiang Weng; Alberto Feletti; Andrew T Parsa; Russell O Pieper
A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Cancer research 2009;69(20):7911-6.
2009: Courtney Crane; Amith Panner; Russell O Pieper; Jack Arbiser; Andrew T Parsa
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(6):585-92.
2009: Seongmi Park; Kimmo J Hatanpaa; Yang Xie; Bruce E Mickey; Christopher J Madden; Jack Raisanen; Deepti B Ramnarain; Guanghua Xiao; Debabrata Saha; David A Boothman; Dawen Zhao; Robert M Bachoo; Russell O Pieper; Amyn A Habib
The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.
Cancer research 2009;69(7):2809-16.
2009: C A Crane; Amith Panner; J C Murray; S P Wilson; H Xu; Lieping Chen; Jeff Simko; Frederic M Waldman; Russell O Pieper; A T Parsa
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.
Oncogene 2009;28(2):306-12.
2008: Jean Lee Nakamura; Edna Garcia; Russell O Pieper
S6K1 plays a key role in glial transformation.
Cancer research 2008;68(16):6516-23.
2008: Gilson Baia; Stefano Stifani; Edna T Kimura; Michael W McDermott; Russell O Pieper; Anita Lal
Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas.
Neoplasia (New York, N.Y.) 2008;10(6):604-12.
2008: Yunge Zhao; Aizhen Xiao; Charles G diPierro; Rana Abdel-Fattah; Samson Amos; Gerard T Redpath; Joan E Carpenter; Russell O Pieper; Isa M Hussaini
H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.
Glia 2008;56(8):917-24.
2008: John H Chi; Amith Panner; Kristine Cachola; Courtney A Crane; Joseph Murray; Russell O Pieper; C David James; Andrew T Parsa
Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation.
Journal of neurosurgery 2008;108(2):299-303.
2007: Jean Lee Nakamura; Daphne A Haas-Kogan; Russell O Pieper
Glioma invasiveness responds variably to irradiation in a co-culture model.
International journal of radiation oncology, biology, physics 2007;69(3):880-6.
2007: Amith Panner; Joseph C Murray; Mitchel S Berger; Russell O Pieper
Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma.
Cancer research 2007;67(19):9482-9.
2007: Masayuki Kanamori; Tomohiro Kawaguchi; Janice M Nigro; Burt Feuerstein; Mitchel S Berger; Lucio Miele; Russell O Pieper
Contribution of Notch signaling activation to human glioblastoma multiforme.
Journal of neurosurgery 2007;106(3):417-27.
2007: M Katayama; T Kawaguchi; Mitchel S Berger; Russell O Pieper
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells.
Cell death and differentiation 2007;14(3):548-58.
2007: Andrew T Parsa; James S Waldron; Amith Panner; Courtney A Crane; Ian F Parney; Jeffrey J Barry; Kristine E Cachola; Joseph C Murray; Tarik Tihan; Michael C Jensen; Paul S Mischel; David Stokoe; Russell O Pieper
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.
Nature medicine 2007;13(1):84-8.
2006: Tomohiro Kawaguchi; Yoji Yamashita; Masayuki Kanamori; Raelene Endersby; Krystof S Bankiewicz; Suzanne J Baker; Gabriele Bergers; Russell O Pieper
The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
Cancer research 2006;66(23):11331-40.
2006: Masayuki Kanamori; Tomohiro Kawaguchi; Mitchel S Berger; Russell O Pieper
Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis.
The Journal of biological chemistry 2006;281(48):37256-64.
2006: Olga K Mirzoeva; Tomohiro Kawaguchi; Russell O Pieper
The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.
Molecular cancer therapeutics 2006;5(11):2757-66.
2006: Amith Panner; Jean L Nakamura; Andrew T Parsa; Pablo Rodriguez-Viciana; Mitchel S Berger; David Stokoe; Russell O Pieper
mTOR-independent translational control of the extrinsic cell death pathway by RalA.
Molecular and cellular biology 2006;26(20):7345-57.
2006: Amith Panner; Andrew T Parsa; Russell O Pieper
Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme.
Expert review of anticancer therapy 2006;6(9):1313-22.
2006: Amith Panner; Andrew T Parsa; Russell O Pieper
Translational regulation of TRAIL sensitivity.
Cell cycle (Georgetown, Tex.) 2006;5(2):147-50.
2005: Amith Panner; C David James; Mitchel S Berger; Russell O Pieper
mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.
Molecular and cellular biology 2005;25(20):8809-23.
2005: Yuchi Hirose; Makoto Katayama; Olga K Mirzoeva; Mitchel S Berger; Russell O Pieper
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence.
Cancer research 2005;65(11):4861-9.
2005: Yuan Rong; Dawn E Post; Russell O Pieper; Donald L Durden; Erwin Van Meir; Daniel J Brat
PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.
Cancer research 2005;65(4):1406-13.
2005: Jean Lee Nakamura; Amelia Karlsson; Nils D Arvold; Alexander R Gottschalk; Russell O Pieper; David Stokoe; Daphne A Haas-Kogan
PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
Journal of neuro-oncology 2005;71(3):215-22.
2004: Ryuta Saito; John Bringas; Amith Panner; Matyas Tamas; Russell O Pieper; Mitchel S Berger; Krystof S Bankiewicz
Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
Cancer research 2004;64(19):6858-62.
2004: Yuichi Hirose; Makoto Katayama; Mitchel S Berger; Russell O Pieper
Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide.
Journal of neurosurgery 2004;100(6):1060-5.
2004: Masayuki Kanamori; Scott R Vanden Berg; Gabriele Bergers; Mitchel S Berger; Russell O Pieper
Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme.
Cancer research 2004;64(8):2751-8.
2003: Yuichi Hirose; Makoto Katayama; David Stokoe; Daphne A Haas-Kogan; Mitchel S Berger; Russell O Pieper
The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents.
Molecular and cellular biology 2003;23(22):8306-15.
2003: Yukihiko Sonoda; Masayuki Kanamori; Dennis F Deen; Shi-Yuan Cheng; Mitchel S Berger; Russell O Pieper
Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Cancer research 2003;63(8):1962-8.
2003: Yuichi Hirose; Emiko Lynn Kreklau; Leonard C Erickson; Mitchel S Berger; Russell O Pieper
Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity.
Journal of neurosurgery 2003;98(3):591-8.
2003: Russell O Pieper
Defined human cellular systems in the study of glioma development.
Frontiers in bioscience : a journal and virtual library 2003;8():s19-27.
2001: Yukihiko Sonoda; T Ozawa; Kenneth Aldape; Dennis F Deen; Mitchel S Berger; Russell O Pieper
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Cancer research 2001;61(18):6674-8.
2001: Yuichi Hirose; Mitchel S Berger; Russell O Pieper
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
Cancer research 2001;61(15):5843-9.
2001: Yukihiko Sonoda; T Ozawa; Yuichi Hirose; Kenneth Aldape; M McMahon; Mitchel S Berger; Russell O Pieper
Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.
Cancer research 2001;61(13):4956-60.
2001: Yuichi Hirose; Mitchel S Berger; Russell O Pieper
p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
Cancer research 2001;61(5):1957-63.